A Phase 3 clinical trial testing ianalumab (VAY736) in combination with Promacta (eltrombopag) in people with primary immune thrombocytopenia (ITP) has met its main…
Immune thrombocytopenia
Whether you're newly diagnosed with ITP or have been managing it for some time, these resources offer guidance on symptoms, treatment options, and emotional support to help you move forward with confidence.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Latest news
Artificial intelligence (AI) can accurately predict a response to the second-line therapy rituximab in children and adolescents with immune thrombocytopenia (ITP), according to a…
